342
Views
3
CrossRef citations to date
0
Altmetric
Report

Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study

ORCID Icon, &
Pages 107-110 | Received 22 Dec 2018, Accepted 15 Mar 2020, Published online: 27 Mar 2020

References

  • Ogbechie-Godec OA, Elbuluk N. Melasma: an up-to-date comprehensive. Dermatol Ther (Heidelb). 2017 Sep;7(3):305–18. doi:10.1007/s13555-017-0194-1.
  • Gokalp H, Akkaya AD, Oram Y. Long-term results in low-fluence 1064-nm Q-Switched Nd: YAG laser for melasma: is it effective? J Cosmet Dermatol. 2016;15(4):420–26.doi:10.1111/jocd.2016.15.issue-4.
  • Kwon SH, Hwang YJ, Lee SK, Park KC. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016;17:E824.
  • Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007 May;46(2):111–16. doi:10.1016/j.jdermsci.2007.01.009.
  • Shankar K, Godse K, Aurangabadkar S, Lahiri K, Mysore V, Ganjoo A, Motlekar SA. Evidence-based treatment for melasma: expert opinion and a review. Dermatol Therapy (Heidelb). 2014;4:165–86.
  • Sarkar R, Arora P, Garg KV. Cosmeceuticals for hyperpigmentation: what is available? JCutan Aesthet Surg. 2013;6(1):4–11.doi:10.4103/0974-2077.110089.
  • Kapicioglu Y, Sarac G, Cenk H. Treatment of erythematotelangiectatic rosacea, facial erythema, and facialtelangiectasia with a 577-nm pro-yellow laser: a case series. Lasers Med Sci. 2019 Feb;34(1):93–98.
  • Kimbrough-Green CK. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994 Jun;130(6):727–33. doi:10.1001/archderm.1994.01690060057005.
  • Kang WH, Yoon KH, Lee E-S, Kim J, Lee KB, Yim H, Sohn S, Im S. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146(2):228–37.doi:10.1046/j.0007-0963.2001.04556.x.
  • Kang HY, Bahadoran P, Suzuki I, Zugaj D, Khemis A, Passeron T, Andres P, Ortonne J-P. In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution. Exp Dermatol. 2010;19:e228–33.
  • Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, Song KY. Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511nm) for treatment of melasma in Asian patients. Dermatol Surg. 2010 Jun;36(6):885–93. doi:10.1111/j.1524-4725.2010.01564.x.
  • Maeda K, Naganuma M. Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. J Photochem Photobiol B: Biol. 1998;47(2–3):136–41.doi:10.1016/S1011-1344(98)00212-7.
  • Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. Int J Women’s Dermatol. 2017;3(1):11–20.doi:10.1016/j.ijwd.2017.01.004.
  • Galeckas KJ, Collins M, Ross EV, Uebelhoer NS. Split face treatment of facial dyschromia: pulsed dye laser with a compression handpiece versus intense pulsed light. Dermatol Surg. 2008;34(5):672–80.doi:10.1111/j.1524-4725.2008.34126.x.
  • Hassan AM, Elfar NN, Rizk OM, Eissa NY. Pulsed dye laser versus intense pulsed light in melasma: a split-face comparative study. J Dermatolog Treat. 2018 Nov;29(7):725–32. doi:10.1080/09546634.2018.1441487.
  • Va´zquez M, Sa´nchez JL. The efficacy of a broad-spectrum sunscreen in the treatment of melasma. Cutis. 1983;32(1):92–96.
  • Ennes SBP, Paschoalick RC, De Avelar Alchorne MM. A doubleblind comparative placebo-controlled study of the efficacy and tolerability of 4% hydroquinone as a depigmenting agent in melasma. J Dermatol Treat. 2000;11(3):173–79.doi:10.1080/09546630050517333.
  • Hammami Ghorbel H, Boukari F, Fontas E, Montaudié H, Bahadoran P, Lacour JP, Passeron T. Copper bromide laser vs triple-combination cream for the treatment of melasma: a randomized clinical trial. JAMA Dermatol. 2015 Jul;151(7):791–92. doi:10.1001/jamadermatol.2014.5580.
  • Eimpunth S, Wanitphakdeedecha R, Triwongwaranat D, Varothai S, Manuskiatti W. Therapeutic outcome of melasma treatment by dual wavelength (511 and 578 nm) laser in patients with skin phototypes III-V. Clin Exp Dermatol. 2014 Apr;39(3):292–97. doi:10.1111/ced.12267.
  • Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour, J.P. and Ortonne, J.P. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. Arch Dermatol. 2011;147(9):1106–08.doi:10.1001/archdermatol.2011.255.
  • Passeron T. Long-lasting effect of vascular targeted therapy of melasma. J Am Acad Dermatol. 2013;69(3):e141–2.doi:10.1016/j.jaad.2013.02.022.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.